Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleSpecial Communication

A Change Management Case Study for Safe Opioid Prescribing and Opioid Use Disorder Treatment

Randi Sokol, Zev Schuman-Olivier, Maren Batalden, Laura Sullivan and Allen F. Shaughnessy
The Journal of the American Board of Family Medicine January 2020, 33 (1) 129-137; DOI: https://doi.org/10.3122/jabfm.2020.01.190223
Randi Sokol
From Tufts University School of Medicine, Boston, MA (RS, AFS); Department of Psychiatry, Harvard Medical School, Boston, MA (ZS-O); Harvard Medical School, Boston, MA (MB); Malden Family Medicine Center, Cambridge Health Alliance, Malden, MA (LS, RS, AFS).
MD, MPH, MMedEd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zev Schuman-Olivier
From Tufts University School of Medicine, Boston, MA (RS, AFS); Department of Psychiatry, Harvard Medical School, Boston, MA (ZS-O); Harvard Medical School, Boston, MA (MB); Malden Family Medicine Center, Cambridge Health Alliance, Malden, MA (LS, RS, AFS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maren Batalden
From Tufts University School of Medicine, Boston, MA (RS, AFS); Department of Psychiatry, Harvard Medical School, Boston, MA (ZS-O); Harvard Medical School, Boston, MA (MB); Malden Family Medicine Center, Cambridge Health Alliance, Malden, MA (LS, RS, AFS).
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Sullivan
From Tufts University School of Medicine, Boston, MA (RS, AFS); Department of Psychiatry, Harvard Medical School, Boston, MA (ZS-O); Harvard Medical School, Boston, MA (MB); Malden Family Medicine Center, Cambridge Health Alliance, Malden, MA (LS, RS, AFS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Allen F. Shaughnessy
From Tufts University School of Medicine, Boston, MA (RS, AFS); Department of Psychiatry, Harvard Medical School, Boston, MA (ZS-O); Harvard Medical School, Boston, MA (MB); Malden Family Medicine Center, Cambridge Health Alliance, Malden, MA (LS, RS, AFS).
PharmD, MMedEd
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

References

  1. 1.↵
    2018 Annual Surveillance Report of Drug-Related Risks and Outcomes — United States. Surveillance Special Report. Washington, DC: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2018. (Accessed June 10, 2019, at https://www.cdc.gov/drugoverdose/pdf/pubs/2018-cdc-drug-surveillance-report.pdf).
  2. 2.↵
    1. Chen JH,
    2. Humphreys K,
    3. Shah NH,
    4. Lembke A
    . Distribution of opioids by different types of Medicare prescribers. JAMA Intern Med 2016;176:259–61.
    OpenUrl
  3. 3.↵
    1. Vowles KE,
    2. McEntee ML,
    3. Julnes PS,
    4. Frohe T,
    5. Ney JP,
    6. van der Goes DN
    . Rates of opioid misuse, abuse, and addiction in chronic pain: a systematic review and data synthesis. Pain 2015;156:569–76.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Anson P
    . AMA drops pain as vital sign. Available from: https://www.painnewsnetwork.org/stories/2016/6/16/ama-drops-pain-as-vital-sign. Published June 16, 2016.
  5. 5.↵
    1. Porter J,
    2. Jick H
    . Addiction rare in patients treated with narcotics. N Engl J Med 1980;302:123.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Leshner AI
    . Addiction is a brain disease, and it matters. Science 1997;278:45–7.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    1. Volkow ND,
    2. Koob GF,
    3. McLellan AT
    . Neurobiologic advances from the brain disease model of addiction. N Engl J Med 2016;374:363–71.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Compton WM,
    2. Blanco C,
    3. Wargo EM
    . Integrating addiction services into general medicine. JAMA 2015;314:2401–2.
    OpenUrl
  9. 9.↵
    1. Dowell D,
    2. Haegerich TM,
    3. Chou R
    . CDC guideline for prescribing opioids for chronic pain—United States, 2016. MMWR Recomm Rep 2016;65:1–49.
    OpenUrlCrossRefPubMed
  10. 10.↵
    Mass.gov. Massachusetts Prescription Awareness Tool (MassPAT). Available from: https://www.mass.gov/guides/massachusetts-prescription-awareness-tool-masspat. Published 2019. Accessed June 10, 2019.
  11. 11.↵
    1. Huhn AS,
    2. Dunn KE
    . Why aren't physicians prescribing more buprenorphine? J Subst Abuse Treat 2017;78:1–7.
    OpenUrlPubMed
  12. 12.↵
    1. Miotto K,
    2. Hillhouse M,
    3. Donovick R,
    4. et al
    . Comparison of buprenorphine treatment for opioid dependence in 3 settings. J Addict Med 2012;6:68–76.
    OpenUrlPubMed
  13. 13.↵
    1. Hutchinson E,
    2. Catlin M,
    3. Andrilla CH,
    4. Baldwin LM,
    5. Rosenblatt RA
    . Barriers to primary care physicians prescribing buprenorphine. Ann Fam Med 2014;12:128–33.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    1. Nelson EC
    . Value by design: developing clinical microsystems to achieve organizational excellence, 1st ed. San Francisco: Jossey-Bass; 2011.
  15. 15.↵
    1. Burnes B
    . Kurt Lewin and the planned approach to change: a re-appraisal. J Manag Stud 2004;41:977–1002.
    OpenUrl
  16. 16.↵
    1. Peters TJ,
    2. Waterman J,
    3. Robert H
    . In search of excellence. New York: Harper Collins; 2006.
  17. 17.↵
    1. Sokol R,
    2. Albanese C,
    3. Chaponis D,
    4. et al
    . Why use group visits for opioid use disorder treatment in primary care? A patient-centered qualitative study. Subst Abus 2018:39:52–58.
    OpenUrl
  18. 18.↵
    1. Sokol R,
    2. LaVertu AE,
    3. Morrill D,
    4. Albanese C,
    5. Schuman-Olivier Z
    . Group-based treatment of opioid use disorder with buprenorphine: a systematic review. J Subst Abuse Treat 2018;84:78–87.
    OpenUrl
  19. 19.↵
    1. Sokol R,
    2. Albanese M,
    3. Albanese C,
    4. et al
    . Implementing group visits for opioid use disorder: a case series. Subst Abus 2019;1–7.
  20. 20.↵
    American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American College of Physicians (ACP), American Osteopathic Association (AOA). Joint Principles of the Patient-Centered Medical Home 2007. Available from: https://www.aafp.org/dam/AAFP/documents/practice_management/pcmh/initiatives/PCMHJoint.pdf. Published 2007. Accessed September 20, 2019.
  21. 21.↵
    1. Lyon RK,
    2. Slawson J
    . An organized approach to chronic disease care. Fam Pract Manag 2011;18:27–31.
    OpenUrlPubMed
  22. 22.↵
    Putting group visits Into practice. A practical overview to preparation, implementation, and maintenance of group visits at Massachusetts General Hospital. 2012. Available from: https://www.sgim.org/File%20Library/SGIM/Meetings/Annual%20Meeting/Meetign%20Content/AM%2014%20handouts/WE04-STEPHANIE-EISENSTAT.pdf. Published 2012. Accessed June 10, 2019.
  23. 23.↵
    1. Safford BH,
    2. Manning C
    . Six characteristics of effective practice teams. Fam Pract Manag 2012;19:26–30.
    OpenUrlPubMed
  24. 24.↵
    1. Vroom VH,
    2. Yetton PW
    . Leadership and decision-making. Pittsburgh, PA: University of Pittsburgh Press; 1973.
  25. 25.↵
    1. Sismondo S
    . How to make opinion leaders and influence people. CMAJ 2015;187:759–760.
    OpenUrlFREE Full Text
  26. 26.↵
    1. Sommers LS,
    2. Morgan L,
    3. Johnson L,
    4. Yatabe K
    . Practice inquiry: clinical uncertainty as a focus for small-group learning and practice improvement. J Gen Intern Med 2007;22:246–52.
    OpenUrlPubMed
  27. 27.↵
    1. Rogers EM
    . Diffusion of innovations, 3rd ed. New York, NY: The Free Press; London: Collier Macmillan; 1983.
  28. 28.↵
    1. Kotter JP
    . Leading change. Boston: Harvard Business Review Press; 2012.
  29. 29.↵
    1. Thaler RH,
    2. Sunstein CR
    . Nudge: improving decisions about health, wealth, and happiness. New York: Penguin Books; 2009.
  30. 30.↵
    1. Kotter JP,
    2. Schlesinger LA
    . Choosing strategies for change. Harv Bus Rev 1979;57:106–14.
    OpenUrlPubMedWeb of Science
  31. 31.↵
    1. Collins J
    . Good to great: why some companies make the leap and others don't. New York: HarperCollins; 2001.
  32. 32.↵
    1. Nutting PA,
    2. Miller WL,
    3. Crabtree BF,
    4. Jaen CR,
    5. Stewart EE,
    6. Stange KC
    . Initial lessons from the first national demonstration project on practice transformation to a patient-centered medical home. Ann Fam Med 2009;7:254–60.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 33 (1)
The Journal of the American Board of Family Medicine
Vol. 33, Issue 1
January-February 2020
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A Change Management Case Study for Safe Opioid Prescribing and Opioid Use Disorder Treatment
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
7 + 2 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
A Change Management Case Study for Safe Opioid Prescribing and Opioid Use Disorder Treatment
Randi Sokol, Zev Schuman-Olivier, Maren Batalden, Laura Sullivan, Allen F. Shaughnessy
The Journal of the American Board of Family Medicine Jan 2020, 33 (1) 129-137; DOI: 10.3122/jabfm.2020.01.190223

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A Change Management Case Study for Safe Opioid Prescribing and Opioid Use Disorder Treatment
Randi Sokol, Zev Schuman-Olivier, Maren Batalden, Laura Sullivan, Allen F. Shaughnessy
The Journal of the American Board of Family Medicine Jan 2020, 33 (1) 129-137; DOI: 10.3122/jabfm.2020.01.190223
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Conclusion
    • Appendix
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • The Most Frequently Read Articles of 2020
  • Family Medicine and the "New" Opioid Epidemic
  • Google Scholar

More in this TOC Section

  • In Defense of Generalists: Primary Care Observations Have Systematic Advantages
  • Looking Back to Move Forward: Reflections of PBRN Directors
  • Building a Primary Care Research Agenda for Latino Populations in the Setting of the Latino Paradox: A Report from the 2023 Latino Primary Care Summit
Show more Special Communication

Similar Articles

Keywords

  • Addictive Behavior
  • Boston
  • Chronic Pain
  • Family Physicians
  • Opioid-Related Disorders
  • Opioids
  • Pain Management
  • Patient-Centered Care
  • Primary Health Care
  • Quality Improvement

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire